<a href="https://laohu8.com/S/PMN">ProMIS Neurosciences Inc</a>. Announces New Compensation Agreement for Chief Scientific Officer Neil Cashman, Including $500,000 CAD Salary and Equity Award
ProMIS Neurosciences Inc. has announced a new employment agreement with Dr. Neil Cashman, who will continue in his role as Chief Scientific Officer. Under the amended terms, Dr. Cashman will receive an annual base salary of $500,000 CAD and will be eligible for an annual discretionary bonus targeted at 35% of his base salary. In addition, he has been granted an option to purchase 165,000 company shares, with 25% vesting after one year and the remainder vesting monthly over the following three years. The agreement also provides for nine months of severance pay and continued benefits in the event of termination without cause or a change in control of the company, with accelerated vesting of stock options in the latter scenario. Dr. Cashman remains a member of the company's board of directors.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProMIS Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-095032), on September 30, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.